192 related articles for article (PubMed ID: 35418046)
1. Incidence of acute otitis media in children < 16 years old in Germany during 2014-2019.
Hu T; Podmore B; Barnett R; Beier D; Galetzka W; Qizilbash N; Haeckl D; Weaver J; Boellinger T; Mihm S; Petigara T
BMC Pediatr; 2022 Apr; 22(1):204. PubMed ID: 35418046
[TBL] [Abstract][Full Text] [Related]
2. Incidence of acute otitis media from 2003 to 2019 in children ≤ 17 years in England.
Mohanty S; Podmore B; Cuñado Moral A; Weiss T; Matthews I; Sarpong E; Méndez I; Qizilbash N
BMC Public Health; 2023 Jan; 23(1):201. PubMed ID: 36717794
[TBL] [Abstract][Full Text] [Related]
3. Incidence of acute otitis media in children in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998-2018.
Hu T; Done N; Petigara T; Mohanty S; Song Y; Liu Q; Lemus-Wirtz E; Signorovitch J; Sarpong E; Weiss T
BMC Infect Dis; 2022 Mar; 22(1):294. PubMed ID: 35346092
[TBL] [Abstract][Full Text] [Related]
4. The effect of pneumococcal conjugated vaccines on occurrence of recurrent acute otitis media among infants diagnosed with acute otitis media at an age younger than 2 months.
Ziv O; Adelson D; Sadeh R; Kordeluk S; El-Saied S; Leibovitz E; Kraus M; Kaplan D
Eur J Pediatr; 2023 Jun; 182(6):2873-2879. PubMed ID: 37052673
[TBL] [Abstract][Full Text] [Related]
5. Economic burden of acute otitis media, pneumonia, and invasive pneumococcal disease in children in the United States after the introduction of 13-valent pneumococcal conjugate vaccines during 2014-2018.
Hu T; Song Y; Done N; Mohanty S; Liu Q; Sarpong EM; Lemus-Wirtz E; Signorovitch J; Weiss T
BMC Health Serv Res; 2023 Apr; 23(1):398. PubMed ID: 37098521
[TBL] [Abstract][Full Text] [Related]
6. Pneumococcal Conjugated Vaccines Decreased Acute Otitis Media Burden: A Population-Based Study in Israel.
Marom T; Tshori S; Shefer G; Pitaro J
J Pediatr; 2021 Aug; 235():233-238.e3. PubMed ID: 33894263
[TBL] [Abstract][Full Text] [Related]
7. Impact of the 13-valent pneumococcal conjugate vaccine on the incidences of acute otitis media, recurrent otitis media and tympanostomy tube insertion in children after its implementation into the national immunization program in Turkey.
Soysal A; Gönüllü E; Yıldız I; Aydemir G; Tunç T; Fırat Y; Erdamar B; Karaböcüoğlu M
Hum Vaccin Immunother; 2020; 16(2):445-451. PubMed ID: 31424317
[TBL] [Abstract][Full Text] [Related]
8. Incidence of pneumococcal disease in children ≤48 months old in the United States: 1998-2019.
Mohanty S; Done N; Liu Q; Song Y; Wang T; Gaburo K; Sarpong EM; White M; Weaver JP; Signorovitch J; Weiss T
Vaccine; 2024 Apr; 42(11):2758-2769. PubMed ID: 38485640
[TBL] [Abstract][Full Text] [Related]
9. Trends in healthcare utilization and costs associated with acute otitis media in the United States during 2008-2014.
Tong S; Amand C; Kieffer A; Kyaw MH
BMC Health Serv Res; 2018 May; 18(1):318. PubMed ID: 29720156
[TBL] [Abstract][Full Text] [Related]
10. A Retrospective Database Analysis to Estimate the Burden of Acute Otitis Media in Children Aged <15 Years in the Veneto Region (Italy).
Barbieri E; Porcu G; Hu T; Petigara T; Senese F; Prandi GM; Scamarcia A; Cantarutti L; Cantarutti A; Giaquinto C
Children (Basel); 2022 Mar; 9(3):. PubMed ID: 35327808
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of Acute Otitis Media in the Postpneumococcal Conjugate Vaccine Era.
Kaur R; Morris M; Pichichero ME
Pediatrics; 2017 Sep; 140(3):. PubMed ID: 28784702
[TBL] [Abstract][Full Text] [Related]
12. Influence of pneumococcal conjugate vaccines on acute otitis media in Japan.
Sasaki A; Kunimoto M; Takeno S; Sumiya T; Ishino T; Sugino H; Hirakawa K
Auris Nasus Larynx; 2018 Aug; 45(4):718-721. PubMed ID: 29102419
[TBL] [Abstract][Full Text] [Related]
13. Healthcare resource utilization and cost of pneumococcal disease in children in Germany, 2014-2019: a retrospective cohort study.
Hu T; Podmore B; Barnett R; Beier D; Galetzka W; Qizilbash N; Heckl D; Boellinger T; Weaver J
Pneumonia (Nathan); 2023 Mar; 15(1):7. PubMed ID: 36964592
[TBL] [Abstract][Full Text] [Related]
14. Pneumococcal conjugate vaccines for preventing otitis media.
Fortanier AC; Venekamp RP; Boonacker CW; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
Cochrane Database Syst Rev; 2014 Apr; (4):CD001480. PubMed ID: 24696098
[TBL] [Abstract][Full Text] [Related]
15. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study.
Veenhoven R; Bogaert D; Uiterwaal C; Brouwer C; Kiezebrink H; Bruin J; IJzerman E; Hermans P; de Groot R; Zegers B; Kuis W; Rijkers G; Schilder A; Sanders E
Lancet; 2003 Jun; 361(9376):2189-95. PubMed ID: 12842372
[TBL] [Abstract][Full Text] [Related]
16. Pneumococcal vaccines for preventing otitis media.
Straetemans M; Sanders EA; Veenhoven RH; Schilder AG; Damoiseaux RA; Zielhuis GA
Cochrane Database Syst Rev; 2004; (1):CD001480. PubMed ID: 14973970
[TBL] [Abstract][Full Text] [Related]
17. Burden of acute otitis media in primary care pediatrics in Italy: a secondary data analysis from the Pedianet database.
Marchisio P; Cantarutti L; Sturkenboom M; Girotto S; Picelli G; Dona D; Scamarcia A; Villa M; Giaquinto C;
BMC Pediatr; 2012 Nov; 12():185. PubMed ID: 23190626
[TBL] [Abstract][Full Text] [Related]
18. Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom.
Lau WC; Murray M; El-Turki A; Saxena S; Ladhani S; Long P; Sharland M; Wong IC; Hsia Y
Vaccine; 2015 Sep; 33(39):5072-9. PubMed ID: 26297875
[TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of pneumococcal conjugate vaccination against acute otitis media in children: a review.
Boonacker CW; Broos PH; Sanders EA; Schilder AG; Rovers MM
Pharmacoeconomics; 2011 Mar; 29(3):199-211. PubMed ID: 21250759
[TBL] [Abstract][Full Text] [Related]
20. Tympanostomy tubes for children with acute otitis media.
Griffiths JL; Goldman RD
Can Fam Physician; 2022 May; 68(5):345-347. PubMed ID: 35552224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
